(Credit: Channel NewsAsia)
One of our BizSpark startups, NephTech, was recently featured in a Channel NewsAsia feature.
NephTech Pte Ltd is a medical technology company dedicated to provide patients and dialysis centres with an evidence-based approach to vascular access (VA) surveillance and management. Vascular access (VA) is hemodialysis patient’s lifeline, as it allows removal of body waste and excess water through hemodialysis, and without which patients do not survive beyond several days.. The company has conceptualized and is developing an innovative low cost VA surveillance technology for dialysis centres to address shortcomings of current state-of-the-art to achieve their Quality Initiative outcomes and reduce occurrences of lost revenues through early predictive clinical indications. This, NephTech strongly believes, addresses a vital unmet need to reduce the heavy financial expenditures in the hemodialysis space.
To find out about NephTech and their product offering, please visit their official website at http://www.nephtech.sg/
Check out their Channel NewsAsia feature below:
Follow